Stem Cell Research (Mar 2023)

Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing

  • Jeffrey Aalders,
  • Laurens Léger,
  • Anthony Demolder,
  • Laura Muiño Mosquera,
  • Paul Coucke,
  • Björn Menten,
  • Julie De Backer,
  • Jolanda van Hengel

Journal volume & issue
Vol. 67
p. 103036

Abstract

Read online

Marfan syndrome is an autosomal dominant genetic disorder resulting from pathogenic variants in FBN1 gene. FBN1 encodes for fibrillin-1, an important extracellular matrix protein. Impaired fibrillin-1 affects multiple organ systems, including the cardiovascular system. We generated an iPSC line carrying a heterozygous variant c.7754 T > C (p.Ile2585Thr, missense) in FBN1 from a patient with Marfan syndrome. Also, an isogenic control is generated, where the pathogenic variant is repaired using CRISPR-Cas9. This isogenic pair provides a valuable resource for in vitro disease modelling.